Milestone Scientific to Present at MicroCap Rodeo’s Winter Wonderland Best Ideas Conference on Wednesday, February 9
February 07 2022 - 9:00AM
Milestone Scientific Inc. (NYSE:MLSS), a leading
developer of computerized drug delivery instruments, that provide
painless and precise injections, today announced that the Company
has been invited to present at The MicroCap Rodeo’s 2nd Annual
Winter Wonderland Best Ideas Conference, which is being held
virtually on February 8 - 11, 2022.
Arjan Haverhals, Chief Executive Officer of
Milestone Scientific, is scheduled to present on Wednesday,
February 9, 2022 at 10:30 AM Eastern Time. The webcast and replay
of the Company’s presentation can be accessed at
https://www.webcaster4.com/Webcast/Page/2840/44551 and on the
investor relations section of Milestone Scientific’s website at
www.milestonescientific.com/investors/news-events. Management will
also be participating in virtual one-on-one meetings with
registered investors.
To receive additional information, request an invitation or to
schedule a one-on-one meeting, please email
angie.goertz@issuerdirect.com. Investors can register for the
conference here.
About the Winter Wonderland Best Ideas
Virtual Investor ConferenceThe MicroCap Rodeo is hosting
its 2nd Annual Winter Wonderland Best Ideas Virtual Investor
Conference with 25-minute virtual presentations on February 8-9,
2022 and one-on-ones for qualified institutional investors on
February 10-11, 2022. Qualified institutional investors recommended
each of the companies represented as one of their best ideas. For
more information, please visit the event website:
https://microcaprodeo.com/.
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS), a technology focused
medical research and development company that patents, designs and
develops innovative injection technologies and instruments for
medical, dental and cosmetic applications. Milestone Scientific’s
computer-controlled systems are designed to make injections
precise, efficient and increase the overall patient comfort and
safety. Their proprietary DPS Dynamic Pressure Sensing Technology®
instruments is the platform to advance the development of
next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view the MLSS brand video or visit
milestonescientific.com.
SOURCE: Milestone Scientific Inc.
Contact:David Waldman or Natalya
RudmanCrescendo Communications, LLCEmail: mlss@crescendo-ir.comTel:
212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Apr 2023 to Apr 2024